Polymetastatic cancer, a condition where cancer has spread to more than 10 spots throughout the body, often leaves patients with limited treatment options. Recent advancements in cancer therapy have focused on high-precision radiation treatments to combat this extensive metastasis. Researchers from
The pharmaceutical and medical technology sectors have long grappled with the complexities of clinical trial management. Traditionally, these processes involved disparate systems and manual workflows, leading to inefficiencies, data silos, and delays. However, the advent of electronic quality
The recent moves by the Trump administration have cast a shadow of uncertainty over the biopharma sector, causing significant turmoil among companies relying on federal grants for clinical trials and drug development. The Office of Management and Budget (OMB) issued a memo on Monday that threatened
In a significant development in avian flu research, scientists from the University of Pittsburgh and the NIH Vaccine Research Center have crafted an innovative antibody therapy aimed at tackling the severe H5N1 avian flu virus in monkeys. This new therapy focuses on a broadly neutralizing antibody,
A recent study published in the American Society of Hematology's journal, Blood, has dispelled the long-held belief that sickle cell trait (SCT) can lead to sudden death, particularly under conditions of physical exertion. This misconception has disproportionately affected Black males with SCT,
The healthcare domain is witnessing a remarkable shift with the introduction of "TBorNotTB," a state-of-the-art clinical decision support system (CDSS) specifically designed for the evaluation of suspected tuberculosis (TB) cases in hospitals. The primary function of TBorNotTB is to aid healthcare
